McKesson Ventures, LLC - 28 Oct 2021 Form 4/A - Amendment Insider Report for Augmedix, Inc.

Role: Director, 10%+ Owner
Signature: /s/ David Schulte, Senior Vice President and Managing Director of MCKESSON VENTURES, LLC
Issuer symbol: N/A
Transactions as of: 28 Oct 2021
Net transactions value: +$450,000
Form type: 4/A - Amendment
Filing time: 20 Sep 2022, 18:17:02 UTC
Date Of Original Report: 01 Nov 2021
Next filing: 22 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AUGX	Common Stock	Purchase	$450,000	+112,500	+2.9%	$4.00	4,047,606	28 Oct 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are held of record by McKesson Ventures LLC ("McKesson"). Jennifer M. Carter, a member of the Issuer's board of directors, is an executive vice president and chief strategy and business development officer at McKesson. As a result, McKesson is a director by deputization for Section 16 purposes.

Remarks:

This amendment is being filed to amend the original Form 4 filed on November 1, 2021 (the "Original Form 4") to correct the amount of securities acquired in Column 4 of Table I and amount of securities beneficially owned in Column 5 of Table I which were inadvertently incorrectly reported in the Original Form 4. All other information in the Original Form 4 remains unchanged.